Soeiro T, Pradel V, Lapeyre-Mestre M, Micallef J. Systematic assessment of non-medical use of prescription drugs using doctor-shopping indicators: A nationwide, repeated cross-sectional study. Addiction. 2023 May 19. doi: 10.1111/add.16261. Epub ahead of print. PMID: 37203878
L. Diaz, C. Eiden, E. Jouanjus et al., Alprazolam misuse: Analysis of French Addictovigilance Network data from 2011 to 2020, Therapies
Aquizerate A, Laforgue EJ, Istvan M, Rousselet M, Gerardin M, Jouanjus E, Libert F; French Addictovigilance Network; Guerlais M, Victorri-Vigneau C. French national addictovigilance follow-up of zolpidem between 2014 and 2020: evolution of drug abuse, misuse and dependence before and after the regulatory change. Eur J Public Health. 2023 Feb 7:ckad003. doi: 10.1093/eurpub/ckad003. Epub ahead of print. …
Pour compléter les éléments d’actualité concernant les problématiques d’usage du protoxyde d’azote, vous trouverez les données récentes, à l’échelle européenne, publiées par l’Observatoire Européen des Drogues et des Toxicomanies (l’EMCDDA), en décembre 2022. Recreational use of nitrous oxide — a growing concern for Europe. Leon Van Aerts, Joanna de Morais (1), Michael Evans-Brown (1), Rita …
Rapport de l’EMCDDA sur le protoxyde d’azote Lire la suite »
Peyriere H, Jacquet JM, Peries M, Tribout V, Broche B, Mauboussin JM, Makinson A, Perrollaz C, Ferreyra M, Rouanet I, Montoya-Ferrer A, El-Majjaoui S, Corriol-Bonifas F, Fraisse T, Grau F, Laureillard D, Nagot N, Reynes J, Donnadieu-Rigole H. Chemsex in HIV pre-exposure prophylaxis users: Assessment of mood disorders and addictive behavior. Fundam Clin Pharmacol. 2022 Nov 20. …
Robert M, Jouanjus E, Khouri C, Fouilhé Sam-Laï N, Revol B. The opioid epidemic: A worldwide exploratory study using the WHO pharmacovigilance database. Addiction. 2022 Nov 4. doi: 10.1111/add.16081. Epub ahead of print. PMID: 36331523.
Blayac L, Ponte C, Lavaud M, Micallef J, Lapeyre-Mestre M. Increase of cannabis and cocaine use by pregnant women in France from 2005 to 2018: Insights of the annual cross sectional OPPIDUM survey. Therapie. 2022 Oct 8:S0040-5957(22)00171-8. doi: 10.1016/j.therap.2022.10.003. Epub ahead of print. PMID: 36283856.
Lapeyre-Mestre M. Addictovigilance in women, the hidden part of the iceberg? Therapie. 2022 Oct 7:S0040-5957(22)00175-5. doi: 10.1016/j.therap.2022.10.006. Epub ahead of print. PMID: 36280399.
Bouquet E, Eiden C, Fauconneau B, Pion C; French Addictovigilance Network (FAN), Pain S, Pérault-Pochat MC. Adverse events of recreational cannabis use during pregnancy reported to the French Addictovigilance Network between 2011 and 2020. Sci Rep. 2022 Oct 3;12(1):16509. doi: 10.1038/s41598-022-19197-2. PMID: 36192621.
Pain S, Bouquet E, Coulon M, Fauconneau B, Perault-Pochat MC. A Withdrawal Syndrome After a Switch of Phenibut to Another γ-Aminobutyric Acid Agonist. J Clin Psychopharmacol. 2022 Sep-Oct 01;42(5):500-501. doi: 10.1097/JCP.0000000000001578. Epub 2022 Aug 6. PMID: 35943411.